Private Equity

BioVie faces a pivotal moment, touting breakthrough drugs for Alzheimer's and cirrhosis while navigating clinical setbacks and financial pressures.

As cardiovascular disease affects nearly half of US adults, experts are urging a shift to existing, life-saving therapies that are widely ignored.

A five-year pivot from office buildings to luxury apartments culminates in a blockbuster private buyout, validating a risky strategy and igniting the market.

Madison Capital Group offers a new DST for a luxury Asheville community, tapping a hot market facing a surge in supply and evolving economic crosscurrents.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.

With stellar trial data and a fast-tracked FDA submission, CG Oncology prepares for a pivotal presentation at the TD Cowen Health Care Conference.

A massive $500 million investment from top private equity firms will accelerate Vero Networks' mission to build high-speed fiber across the U.S.

A new high-grade discovery deep beneath a century-old mine could revive a legendary BC mining district and bolster Canada's critical mineral supply.

Anavex Life Sciences adds AMEOS Group CEO Dr. Axel Paeger to its board, a strategic move signaling a push into European markets for its CNS therapies.

C4 Therapeutics begins a crucial study for its oral protein degrader, cemsidomide, offering new hope for heavily treated multiple myeloma patients.

The biotech firm slashed a major acquisition hurdle in a deal with HealthCare Royalty, signaling strong confidence in its cancer drug ZYNLONTA's future.

Keurig's ubiquitous K-Cup pods are now recyclable in Ontario, marking a pivotal test for the province's new producer-funded waste system.

The pizza giant posts robust sales and expands market share, crediting its 'Hungry for MORE' strategy and rewarding investors with a major dividend boost.

With key hires in exploration, finance, and permitting, Ambler Metals is accelerating its plan to unlock Alaska’s vast copper and cobalt resources.

The regenerative agriculture firm is betting on a new capital markets strategy to boost its profile and attract investment in a competitive green-tech space.

TOMI Environmental Solutions secures crucial biocidal product approvals in Great Britain and NI, paving the way for a major European market expansion.

LIXIL has reached 103 million people with safe sanitation, not through charity, but by building a revolutionary social business from the ground up.

Arrotex secures rights to an innovative, FDA-approved nanotech eye drop, promising faster, simpler recovery for thousands of surgical patients.

The diagnostics firm has 180 days to boost its market value after a Nasdaq warning, placing immense pressure on its turnaround and high-stakes biosensor plans.

Responding to strong investor demand, American Atomics upsized its private placement to $2M, fueling its ambitious North American uranium supply chain strategy.